TRIMTECH Therapeutics
Developer of a targeted protein degradation platform designed to address neurodegenerative diseases by degrading toxic protein aggregates. The company's platform offers oral therapeutics with specific...
Valuation
$0
Share Price
N/A
Total Raised
$31.7M
Last Round
N/A